Peak and decline in cancer incidence, mortality, and prevalence at old ages

Abstract

BACKGROUND: Cancer incidence and mortality increase with age through much of adulthood, but earlier work has found that these rates decline among the very elderly. To compare incidence and mortality at the oldest ages, the authors investigated both in the same large population, which comprised 9.5% of the United States in 2000. The authors also report age-specific prevalence among the elderly, which has received little attention. METHODS: Twentythree cancer types were studied in men, and 24 cancer types were studied in women. Patient records were obtained from the SEER 9 cancer registries, and population figures were taken from the 2000 US Census. The authors explored the reliability of census data on the oldest old, which has been questioned. RESULTS: Age-specific incidence, prevalence, and mortality results are presented for the years 1998 to 2002. Incidence and mortality usually decreased or plateaued at very old ages. Prevalence usually decreased swiftly at ages >90 years. When there was statistical power, incidence normally peaked between ages 75 years and 90 years, dropping abruptly afterward. With several large exceptions, peak incidence and mortality coincided within AE5 years. Both rates often trended toward zero among centenarians, who may be asymptomatic or insusceptible. CONCLUSIONS: The current results were found to be consistent with autopsy and survival studies. Most age-specific models of carcinogenesis are based on cancer rate data for ages <85 years. The authors argue that these models could not fit the current results without fundamental modification and outline biologic mechanisms for such modification, mostly cellular and tissue senescence. They also recommend caution to researchers who use census data on the very elderly. Cancer 2012;118:1371-

Incidental findings in computed tomographic angiography for planning percutaneous aortic valve replacement: advanced age, increased cancer prevalence?

“…Interestingly, recent research has revealed that cancer incidence rates after about the age of 75 years tend to flatten and thereafter sharply decrease. Possible explanations for this observation are: cells become senescent losing their proliferative potential; age-dependent remodelling of the immune system leads to an increased number of natural killer cells; decreased exposure to carcinogens; and limitation of angiogenesis due to atherosclerosis (29). This may explain the lower than expected prevalence of malignancies in our study patients, in whom only three new lesions were highly suggestive of malignancy.…”

DNA repair systems

“…Time, however, is not an independent factor in carcinogenesis, as it is known that cancer prevalence increases with age, but not in a linear fashion. Studies of cancer prevalence among the elderly (>75 years of age) show that in the age group over 90 the prevalence of cancer is lower than in those before 90 [1178][1179][1180]. More specifically, these authors found prevalence of cancer of 35% in the group of elderly individuals aged 75-79; 20% in those over 90, and 15% among centenarians.…”

Evacuation Criteria after a Nuclear Accident: A Personal Perspective

“…(e.g. Harding et al 2011) It is unclear whether my recommendation of an immediate reversion to the pre-1980 radiation safety levels would have enabled the Tokyo Electric Power Company (TEPCO) to control the reactors any better in the crucial first day. I think they would and that is implied in INPO (2011).…”